Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

Factors determining bone mineral density loss in chronic hepatitis B patients: is tenofovir disoproxil fumarate the main culprit?

(2011) U. S. Gill et al.   GUT

HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A–H and its use in antiviral phenotyping assays

(2011) Yuao Zhu et al.   JOURNAL OF VIROLOGICAL METHODS

Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses

(2010) Gloria Woo et al.   GASTROENTEROLOGY

Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence

(2010) Brent C. Taylor et al.   HEPATOLOGY

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B

(2010) Chien-Jen Chen et al.   HEPATOLOGY

Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options

(2010) Maureen M. Jonas et al.   HEPATOLOGY

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

(2009) Florian van Bömmel et al.   HEPATOLOGY

Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B

(2009) B. A. Haber et al.   PEDIATRICS

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE